Evaluation of FLT-PET-CT as an Imaging Biomarker of Proliferation in Primary Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined With Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18f]iso-1 PET/CT

Clinical Cancer Research
Cancer ResearchOncology
2019English

Role of 18FDG PET/CT in Breast Cancer

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Medicine
2018English

18f-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2019English

miR-17 as a Diagnostic Biomarker Regulates Cell Proliferation in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

18f-FLT PET/CT Imaging in Patients With Advanced Solid Malignancies Treated With Axitinib on an Intermittent Dosing Regimen

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

18f-FDG PET/CT Parameters as Imaging Biomarker Is Useful in Oral Squamous Cell Carcinoma Patients

Journal of Japanese Society of Oral Oncology
2017English

PET/CT Evaluation of Cervical Cancer: Spectrum of Disease

Radiographics
MedicineNuclear MedicineRadiologyImaging
2010English

Hybrid Imaging (SPECT/ CT, PET/CT, PET/MR)

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy